biopharmaceutical


Sanofi Announces $2.9 Billion Acquisition of BioPharma Diabetes Drug Maker 

Paris-based Sanofi S.A. announced a definitive agreement to pay $2.9 billion for diabetes drug manufacturer Provention Bio, Inc., a U.S.-based, biopharmaceutical company focused on intercepting…